Prevention and Treatment of Thromboembolic Events in Patients with Cancer: Advances and Challenges

Am J Respir Crit Care Med. 2020 Jul 1;202(1):124-127. doi: 10.1164/rccm.201909-1782RR.
No abstract available

Publication types

  • Comment

MeSH terms

  • Factor Xa Inhibitors
  • Heparin, Low-Molecular-Weight
  • Humans
  • Neoplasms*
  • Venous Thromboembolism*

Substances

  • Factor Xa Inhibitors
  • Heparin, Low-Molecular-Weight